Mr. Mavroudis is a professional portfolio manager specializing in institutional and private portfolios. He focuses on risk management, which is accompanied by in-depth financial market analysis (fundamental, macro and technical) to control the risk undertaken by the portfolios. He invests in all financial instruments globally (stocks, bonds, fx, commodities), restructuring investment portfolios based on prevailing conditions and the needs of each client-investor. Mr. Mavroudis has successfully navigated all ...

Green Thumb Industries rallied last week on renewed hope of cannabis rescheduling from the Trump administration. The news appeared in a Washington Post article released on Thursday. US MSOs and Canadian cannabis LPs saw largeWelcome to the home of The Cannabis Report. I cover the cannabis sector and other sectors. I am most interested in technical stock analysis, option strategies, small cap strategies, and emerging markets. Feel free to contact me with any questions about publicly traded stocks in the cann ...

Green Thumb Industries rallied last week on renewed hope of cannabis rescheduling from the Trump administration. The news appeared in a Washington Post article released on Thursday. US MSOs and Canadian cannabis LPs saw largeWelcome to the home of The Cannabis Report. I cover the cannabis sector and other sectors. I am most interested in technical stock analysis, option strategies, small cap strategies, and emerging markets. Feel free to contact me with any questions about publicly traded stocks in the cann ...

Cannabis stocks surged significantly on Dec. 12, 2025, thanks to reports of President Trump's plans to ease federal marijuana regulations by reclassifying it to Schedule III from a Schedule I. This news sparked gains across major players, boosting investor optimism despite no final policy confirmation.Amplify Seymour Cannabis ETF (CNBS)  rallied more than 54% on the day for its best day on record, as mentioned in CNBC.If reclassified, the move would allow cannabis companies to fall under different tax regul ...

Aurora Cannabis Inc. (NASDAQ:ACB) ranks among the best sin stocks to buy in 2026. Aurora Cannabis Inc. (NASDAQ:ACB) has recently been making significant market growth in Europe and Australia, with the company stating on December 2 that its subsidiary, MedReleaf Australia, has signed a distribution agreement with Leafio, Montu Australia’s wholesale arm. The partnership intends to give medical professionals training materials while expanding patient access to medical cannabis products throughout Australia. ...

服务与作者背景 - 投资研究服务420 Investor于2013年推出 随后科罗拉多州将成人使用大麻合法化 该服务于2023年迁移至Seeking Alpha平台 [1] - 该服务历史上通过模型投资组合、视频和书面材料提供深入的行业覆盖 以帮助投资者了解大麻股票 [1] - 服务创始人兼负责人Alan Brochstein, CFA 是首批专注于大麻行业的投资专业人士之一 自1986年进入证券行业 并于2007年创立AB Analytical Services 提供独立咨询服务 [1] - Alan Brochstein同时也是New Cannabis Ventures的管理合伙人 该机构自2015年起成为大麻行业相关财务信息的主要提供商 [1] 服务内容与覆盖 - 在投资群组420 Investor中 密切跟踪20只股票 并分享投资新闻、财报预览及事后分析 [1] - 群组其他功能包括：一个模型投资组合、每周10个包含图表分析的视频、每周3篇总结文章、每月一份新闻简报以及用于提问的聊天功能 [1] - 作者近期在Seeking Alpha上广泛撰写关于房地产投资信托基金的文章 为期八周 [1]

The cannabis business might soon be a lot more lucrative.Shares of Tilray Brands (TLRY +43.89%) surged 65% this past week, according to data provided by S&P Global Market Intelligence. Investors are hopeful that the Trump administration will move to lessen costly regulations on the beleaguered cannabis industry. A highly anticipated executive orderPresident Donald Trump is reportedly contemplating a reclassification of marijuana from a Schedule I drug to a Schedule III drug, according to The Washington Post ...

U.S.-listed cannabis stocks are back in focus as expectations build around a potential shift in federal marijuana policy. Markets have reacted positively to reports that President Donald Trump is considering directing regulators to reclassify cannabis from Schedule I to Schedule III under the Controlled Substances Act.While such a move would not legalize marijuana outright, it would mark the most significant federal reform in decades, easing regulatory pressure, reducing punitive taxes, and potentially attr ...

Fast money trader Tim Seymour. He's behind of course the Amplify Seymour cannabis ETF which surged nearly 55% today. Its best day on record.Such a good day that Tim comes to us in a hoodie. Tim >> in a hoodie. We're talking.Why wouldn't we. Why would I mean the rescheduling that has been something that investors are hoping for. It seems like you get a whiff of it, the stocks go up.You say this is for real this time. Why >> a whiff. No, no pun intended.So I I think it is real. I think it's always been real. ...

Of course, nothing is official until pen is put to paper. However, industry analysts feel certain it will happen. Trump rescheduling marijuana was not an if, in our assessment, but a when,†Ed Groshans of investment firm Compass Point said. Cannabis stocks soared on Friday following news that U.S. president Donald Trump is expected to sign an executive order as soon as Monday that would ultimately ease federal restrictions on marijuana. The order would essentially reclassify marijuana from a Schedule I subst ...